Follow-up study of the treated cohort

DRUG2 trials

Sponsors

University Hospital, Toulouse, Jinling Hospital, China

Conditions

Antineoplastic AgentsCarcinomaCarcinoma, Renal CellFemale Urogenital DiseasesKidney DiseasesKidney NeoplasmsMale Urogenital DiseasesNeoplasms

Phase 3

Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial

RecruitingNCT05032326

University Hospital, ToulousePrader-Willi Syndrome

Start: 2021-09-07End: 2025-04-01Target: 80Updated: 2024-04-30

Unknown Phase

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

RecruitingNCT06676527

Jinling Hospital, ChinaAntineoplastic Agents, Carcinoma, Carcinoma, Renal Cell +10

Start: 2024-09-01End: 2026-09-01Target: 39Updated: 2025-12-05